Director Information

RNS Number : 8886F

Syncona Limited

01 November 2018

 

Syncona Limited

Director Information

1 November 2018

Syncona Limited announces that Robert Hutchinson, a Non-Executive Director and Chair of the Audit Committee, has informed the Company that he has been appointed to the Board of Ravenscroft Holdings Limited, a company listed on The International Stock Exchange, with effect from 1 November 2018.

[ENDS]

Enquiries

Syncona Ltd

Annabel Clay

Tel: [phone]

Citco Fund Services (Guernsey) Limited

Company Secretary

Tel: [phone]

Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com  

About Syncona:

Syncona is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.

We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.

 

END

 

 

RDNLFLFXVBFBFBE